Evidence map›Paper›PMID 37963212›Full record

ArticleCancer research2024

Deep Learning Enables Spatial Mapping of the Mosaic Microenvironment of Myeloma Bone Marrow Trephine Biopsies.

Yeman Brhane Hagos, Catherine S Y Lecat, Dominic Patel, Anna Mikolajczak, Simon P Castillo, Emma J Lyon, Kane Foster, Thien-An Tran, Lydia S H Lee, Manuel Rodriguez-Justo and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Deep Learning in Hematology: From Molecules to Patients.Clinical hematology international · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Yeman Brhane Hagos *Centre for Evolution and Cancer and Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.ORCID 0000-0002-0357-6297
Catherine S Y Lecat *Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.ORCID 0000-0001-9233-6967
Dominic PatelResearch Department of Pathology, University College London Cancer Institute, London, United Kingdom.ORCID 0000-0001-9223-6632
Anna MikolajczakResearch Department of Haematology, University College London Cancer Institute, London, United Kingdom.ORCID 0009-0002-0603-6867
Simon P CastilloCentre for Evolution and Cancer and Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.ORCID 0000-0002-0606-2160
Emma J LyonResearch Department of Haematology, University College London Cancer Institute, London, United Kingdom.ORCID 0009-0004-7264-7177
Kane FosterResearch Department of Haematology, University College London Cancer Institute, London, United Kingdom.ORCID 0000-0002-0330-8305
Thien-An TranResearch Department of Haematology, University College London Cancer Institute, London, United Kingdom.ORCID 0009-0003-4473-0566
Lydia S H LeeResearch Department of Haematology, University College London Cancer Institute, London, United Kingdom.ORCID 0000-0002-6092-8949
Manuel Rodriguez-JustoResearch Department of Pathology, University College London Cancer Institute, London, United Kingdom.ORCID 0000-0001-5007-1761
Kwee L Yong *Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.ORCID 0000-0002-6487-276X
Yinyin Yuan *Centre for Evolution and Cancer and Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.ORCID 0000-0002-8556-4707
CRUK Lung Cancer Centre of Excellence · GBInstitute of Cancer Research · GBLondon Cancer · GB

Funding

The Role of the Microbiome in Cancer Suppression and Susceptibility Across SpeciesU54CA217376 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MALEY, CARLO · 2018 to 2022
$8.6M
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCISR01CA185138 · NCI · DUKE UNIVERSITY · PI HWANG, E.SHELLEY, MALEY, CARLO · 2014 to 2017
$2.0M
Cancer Research UK 28770Medical Research Council MR/S001883/1NCI NIH HHS R01 CA185138NCI NIH HHS U54 CA217376Wellcome Trust
6 · The paper itself

Abstract

Bone marrow trephine biopsy is crucial for the diagnosis of multiple myeloma. However, the complexity of bone marrow cellular, morphologic, and spatial architecture preserved in trephine samples hinders comprehensive evaluation. To dissect the diverse cellular communities and mosaic tissue habitats, we developed a superpixel-inspired deep learning method (MoSaicNet) that adapts to complex tissue architectures and a cell imbalance aware deep learning pipeline (AwareNet) to enable accurate detection and classification of rare cell types in multiplex immunohistochemistry images. MoSaicNet and AwareNet achieved an AUC of >0.98 for tissue and cellular classification on separate test datasets. Application of MoSaicNet and AwareNet enabled investigation of bone heterogeneity and thickness as well as spatial histology analysis of bone marrow trephine samples from monoclonal gammopathies of undetermined significance (MGUS) and from paired newly diagnosed and posttreatment multiple myeloma. The most significant difference between MGUS and newly diagnosed multiple myeloma (NDMM) samples was not related to cell density but to spatial heterogeneity, with reduced spatial proximity of BLIMP1+ tumor cells to CD8+ cells in MGUS compared with NDMM samples. Following treatment of patients with multiple myeloma, there was a reduction in the density of BLIMP1+ tumor cells, effector CD8+ T cells, and regulatory T cells, indicative of an altered immune microenvironment. Finally, bone heterogeneity decreased following treatment of patients with multiple myeloma. In summary, deep learning-based spatial mapping of bone marrow trephine biopsies can provide insights into the cellular topography of the myeloma marrow microenvironment and complement aspirate-based techniques. SIGNIFICANCE: Spatial analysis of bone marrow trephine biopsies using histology, deep learning, and tailored algorithms reveals the bone marrow architectural heterogeneity and evolution during myeloma progression and treatment.

Indexed as

Deep LearningMonoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaBiopsyBone MarrowHumansTumor Microenvironment

Identifiers

PMID37963212
PMCPMC10831337
OpenAlexW4388667512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.